These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
349 related items for PubMed ID: 3335015
41. ErbB2 oncogene antibodies differentiate between the normal and diseased pancreas, and between chronic pancreatitis and pancreatic cancer. Standop J, Schneider M, Ulrich A, Mathiak G, Brand RE, Buechler MW, Pour PM. Oncol Rep; 2004 Dec; 12(6):1309-15. PubMed ID: 15547756 [Abstract] [Full Text] [Related]
42. Comparative study on the expression of the blood group antigens Le(a), Le(b), Le(x), Le(y) and the carbohydrate antigens CA19-9 and CA-50 in chronic pancreatitis and pancreatic carcinoma. Makovitzky J, Schwenk J. Acta Histochem Suppl; 1990 Dec; 40():143-6. PubMed ID: 2091042 [No Abstract] [Full Text] [Related]
43. Expression of Lewisa, Lewisb, X, and Y blood group antigens in human colonic tumors and normal tissue and in human tumor-derived cell lines. Sakamoto J, Furukawa K, Cordon-Cardo C, Yin BW, Rettig WJ, Oettgen HF, Old LJ, Lloyd KO. Cancer Res; 1986 Mar; 46(3):1553-61. PubMed ID: 3510728 [Abstract] [Full Text] [Related]
44. Sialylated MUC1 mucin expression in normal pancreas, benign pancreatic lesions, and pancreatic ductal adenocarcinoma. Masaki Y, Oka M, Ogura Y, Ueno T, Nishihara K, Tangoku A, Takahashi M, Yamamoto M, Irimura T. Hepatogastroenterology; 1999 Mar; 46(28):2240-5. PubMed ID: 10521973 [Abstract] [Full Text] [Related]
45. Expression of intermediate filaments in normal and neoplastic exocrine pancreas. Santini D, Ceccarelli C, Martinelli GN, Pasquinelli G, Leone O, Marrano D, Mancini AM. Zentralbl Pathol; 1994 Aug; 140(3):247-58. PubMed ID: 7524653 [Abstract] [Full Text] [Related]
46. Expression of various sialylated carbohydrate antigens in malignant and nonmalignant pancreatic tissues. Satomura Y, Sawabu N, Takemori Y, Ohta H, Watanabe H, Okai T, Watanabe K, Matsuno H, Konishi F. Pancreas; 1991 Jul; 6(4):448-58. PubMed ID: 1678888 [Abstract] [Full Text] [Related]
47. Neurotensin receptor-1 mRNA analysis in normal pancreas and pancreatic disease. Wang L, Friess H, Zhu Z, Graber H, Zimmermann A, Korc M, Reubi JC, Büchler MW. Clin Cancer Res; 2000 Feb; 6(2):566-71. PubMed ID: 10690540 [Abstract] [Full Text] [Related]
48. Advantage of cocktail-use of two anti-tumor monoclonal antibodies, KM-93 and KM-231, in serum diagnosis of cancer. Shitara K, Hanai N, Furuya A, Yoshida H. Anticancer Res; 1989 Feb; 9(4):999-1004. PubMed ID: 2479331 [Abstract] [Full Text] [Related]
49. Monoclonal antibody localization of Lewis antigens in fixed tissue. Ernst C, Atkinson B, Wysocka M, Blaszczyk M, Herlyn M, Sears H, Steplewski Z, Koprowski H. Lab Invest; 1984 Apr; 50(4):394-400. PubMed ID: 6368970 [Abstract] [Full Text] [Related]
50. [Preferential expression of cartilage oligomeric matrix protein in degenerating acinar cells in chronic pancreatitis and in chronic pancreatitis-like lesions]. Liao Q, Zhao YP, Kleeff J, Xiao Y, Zimmermann A, Buchler MW, Friess H. Zhonghua Wai Ke Za Zhi; 2003 May; 41(5):328-31. PubMed ID: 12892583 [Abstract] [Full Text] [Related]
53. [Fucosyltransferase producing sialyl Le(a) and sialyl Le(x) carbohydrate antigen in gastrointestinal cancer]. Dohi T, Hashiguchi M. Nihon Rinsho; 1995 Jul; 53(7):1781-5. PubMed ID: 7630019 [Abstract] [Full Text] [Related]
54. Location and distribution of difucoganglioside (VI3NeuAcV3III3Fuc2nLc6) in normal and tumor tissues defined by its monoclonal antibody FH6. Fukushi Y, Kannagi R, Hakomori S, Shepard T, Kulander BG, Singer JW. Cancer Res; 1985 Aug; 45(8):3711-7. PubMed ID: 4016748 [Abstract] [Full Text] [Related]
55. Human pancreatic cancer-associated antigens detected by murine monoclonal antibodies. Yuan SZ, Ho JJ, Yuan M, Kim YS. Cancer Res; 1985 Dec; 45(12 Pt 1):6179-87. PubMed ID: 4063969 [Abstract] [Full Text] [Related]
56. [Carbohydrate antigens as a tumor-associated antigen and prognostic indicators in carcinomas of the breast, esophagus, stomach, colorectum, and pancreas]. Watanabe T, Asai H, Sakamoto J, Narita T, Ichihara T, Yamauchi M, Takagi H. Nihon Geka Gakkai Zasshi; 1991 Sep; 92(9):1098-101. PubMed ID: 1944163 [Abstract] [Full Text] [Related]
57. Potential target antigens for immunotherapy in human pancreatic cancer. Schmitz-Winnenthal FH, Galindo-Escobedo LV, Rimoldi D, Geng W, Romero P, Koch M, Weitz J, Krempien R, Niethammer AG, Beckhove P, Buchler MW, Z'graggen K. Cancer Lett; 2007 Jul 18; 252(2):290-8. PubMed ID: 17320278 [Abstract] [Full Text] [Related]
58. Different expression levels of alpha3/4 fucosyltransferases and Lewis determinants in ovarian carcinoma tissues and cell lines. Escrevente C, Machado E, Brito C, Reis CA, Stoeck A, Runz S, Marmé A, Altevogt P, Costa J. Int J Oncol; 2006 Sep 18; 29(3):557-66. PubMed ID: 16865271 [Abstract] [Full Text] [Related]
59. Expression of Tn, sialosyl Tn, and T antigens in human pancreas. Itzkowitz S, Kjeldsen T, Friera A, Hakomori S, Yang US, Kim YS. Gastroenterology; 1991 Jun 18; 100(6):1691-700. PubMed ID: 1850375 [Abstract] [Full Text] [Related]